VHL and nonpapillary renal cell carcinoma: Activated in response to VHL gene mutations frequently observed in ccRCC, HIF engages with the 5′-(A/G)CGTG-3′ hypoxia-response elements (HREs) within target gene promoters, instigating their transcriptional activation [44,45,46].